Welcome to the MarketReader Minute.

Below are AI-generated insights on today's premarket moves, powered by MarketReader technology.

Tuesday, September 08

Noteworthy macro moves today: Noteworthy US mega-cap moves today: Oracle Corp (ORCL) +5.2%. Intel Corp (INTC) +4.9%. ASML Holding NV (ASML) +3.6%.

Global equity indices are trading generally lower today, with U.S. markets showing mixed results as the Nasdaq 100 rises while the Dow, Russell 2000, and S&P 500 decline. This divergence follows Friday's robust jobs report that indicated nonfarm payrolls rose by 162k in August and the unemployment rate held steady at 4.1%, raising expectations for a potential interest rate hike by the Federal Reserve at its upcoming meeting.

In Europe, equity indices are mixed; while the AEX and Euro Stoxx 50 are higher, the IBEX 35 is lower amid ongoing concerns about geopolitical tensions in the Middle East affecting energy prices and economic stability. The DAX has also faced pressure due to political uncertainty following significant electoral outcomes in Germany.

Recent economic data released today showed France's trade deficit widened to €6.7 billion in July, exceeding expectations of €6 billion and reflecting rising imports amid challenges in export competitiveness. Additionally, Germany reported a trade surplus of €21.3 billion for July despite a decline in exports by 0.8%, indicating mixed signals regarding its economic health.

Market sentiment remains cautious ahead of key inflation data releases later this week from the U.S., including CPI and PPI figures expected to influence future Federal Reserve monetary policy decisions amidst rising geopolitical tensions impacting global markets.

Global X Copper Miners ETF (COPX) [+2.5%]
Copper prices surged to an all-time high of $14,533 per ton due to concerns over potential U.S. tariffs on refined copper imports and tight supply conditions from production cuts in Chile. This increase is positively impacting the Global X Copper Miners ETF, which is trading higher in pre-market hours. The ETF's performance has been bolstered by strong contributions from its top holdings, including HBM and FCX. Additionally, the United States Copper Index Fund has also seen a notable return, reflecting a strong historical correlation with COPX. Overall, the ETF's upward movement aligns with the current dynamics in the copper market.

iShares MSCI Brazil ETF (EWZ) [+1.2%]
In pre-market trading, the iShares MSCI Brazil ETF is advancing, supported by a surge in call option interest and positive performance from key holdings. Record highs in call open interest reflect significant demand, driven by expectations surrounding Brazil's monetary easing cycle and upcoming presidential elections. Notably, the Central Bank's potential shift from restrictive interest rates could lead to multiple expansions in Brazilian equities. The top contributors to the ETF's performance include Petrobras, Vale, and JBS, each showing positive returns. Despite broader global equity indices trading lower due to rising oil prices and geopolitical tensions, EWZ is exhibiting unusual strength, trading higher since Friday's close and positioned notably above its 20-day moving average.

State Street Energy Select Sector SPDR ETF (XLE) [+1.1%]
Oil prices surged in pre-market trading as tensions in the Middle East escalated, with Brent crude approaching $100 per barrel amid threats from Iran and ongoing assaults on Saudi oil facilities. This geopolitical risk is contributing to inflationary pressures and has prompted Goldman Sachs to revise its forecasts for Brent and WTI prices upward. In response, the State Street Energy Select Sector SPDR ETF is gaining, reflecting a strong performance in energy equities, which have recently reached record highs. The ETF's price action follows a successful test of previous resistance levels and is supported by a bullish flag pattern. Major holdings such as ExxonMobil and Chevron are contributing positively to the ETF's performance, further bolstered by rising oil prices.

ORCL | +5.6% | +27.0B
Oracle Corp | Information Technology
Positive sentiment is building around Oracle Corp ahead of its fiscal first-quarter earnings report scheduled for September 10. Mizuho has highlighted the potential for 100% upside, supported by expectations of 28% revenue growth to $19.13 billion. Morgan Stanley raised its price target to $210, citing a favorable outlook on Oracle's transition to cloud infrastructure and strong retail sentiment. Additionally, excitement surrounding OpenAI's GPT-6 Astra and its implications for Oracle's business has contributed to a bullish atmosphere among traders. Social media discussions reflect this optimism, with mentions of strong demand for Oracle's services and anticipated earnings per share guidance between $1.72 and $1.76, surpassing consensus estimates. Overall, Oracle shares are gaining in pre-market trading, reflecting this positive outlook and heightened investor interest.

BP | +2.2% | +15.8B
BP PLC | Energy
BP shares reached a five-week high of 555.80 GBp during pre-market hours on Tuesday, reflecting ongoing investor interest amid favorable market conditions. The stock has gained momentum, with a 5.93% increase over the past four weeks and a notable 31.4% rise over the last year. Additionally, BP announced an offshore production enhancement award aimed at supporting new well development and enhanced recovery for its UK North Sea operations, which is expected to bolster its operational capabilities in that region. The positive price action also aligns with broader sector dynamics, as Suncor Energy Inc has moved higher, indicating potential influences from the integrated oil and gas sector.

ROIV | +19.8% | +6.0B
Roivant Sciences Ltd | Health Care
Roivant Sciences Ltd reported positive results from its Phase 2 PHocus clinical trial for mosliciguat, which demonstrated a significant placebo-adjusted reduction in pulmonary vascular resistance of 56.3% at Week 16, the highest recorded in any randomized controlled trial for this condition. The study also showed improvements in six-minute walk distance and reductions in NT-proBNP levels, indicating the drug's potential efficacy in treating pulmonary hypertension associated with interstitial lung disease. Roivant has initiated the Phase 3 PHrontier study to further evaluate mosliciguat's effectiveness. Following this announcement, shares surged in pre-market trading. Earlier in the session, the stock pulled back from a session high but remains higher since Friday's close.

IONQ | +7.0% | +1.1B
IONQ Inc | Information Technology
IONQ Inc has raised its full-year 2026 revenue outlook to between $450 million and $460 million, significantly up from a previous estimate of $280 million to $290 million. This adjustment follows the recent acquisition of SkyWater Technology, which is expected to enhance manufacturing scale for IONQ's quantum platform. Niccolo de Masi, Chairman and CEO, highlighted the importance of this updated guidance as the company prepares for its inaugural joint Investor Day. Additionally, IONQ published a research paper outlining a strategy for using a 20,000-physical-qubit quantum computer to address cryptographic challenges in under 26 days. As a result of these developments, shares are trading sharply higher in pre-market hours, reflecting strong investor response to the positive outlook and operational advancements.

GPCR | +3.7% | +0.4B
Structure Therapeutics Inc | Health Care
Structure Therapeutics Inc reported positive clinical data for its oral small molecule programs aimed at chronic weight management. The company announced that ACCG-2671, an oral amylin receptor agonist, achieved a 3.3% body weight reduction in its Phase 1/2a trial, with a favorable safety profile and no serious adverse events. Additionally, aleniglipron demonstrated a significant 16.2% mean weight loss at 72 weeks in the ACCESS open-label extension trial, showing no evidence of a plateau in weight loss. These results were disclosed ahead of a scheduled conference call today at 8:30 a.m. ET. Following this announcement, shares are trading higher in pre-market hours, reflecting investor optimism regarding the potential of these compounds.

Thank you for spending a minute with us.

If you have 2 more minutes, watch this demo of the MarketReader Platform: